Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ 41,061	$ (606,044)	$ (859,436)	$ (5,090,321)	$ (7,414,993)	$ 10,020,939
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on derecognition of non-financial asset						(16,951,477)
Goodwill impairment	(0)		(0)		6,083,146	(0)	$ 4,111,079
Amortization of debt discount and deferred finance costs						1,560,173
Amortization of intangible assets						12,841
Warrants issued in connection with private placement						2,905,316
Stock compensation expense						626,243
Change in fair value of derivative	(306,836)		(105,662)		20,758	(37,740)
Loss on debt conversion	94,829				94,829	257,810
Changes in operating assets and liabilities:
Prepaid expenses and other current assets					(39,768)	384
Accounts payable and accrued expenses					367,348	287,590
Accounts payable to related party					(59,750)	(53,961)
Net cash used in operating activities					(948,430)	(1,371,882)
Cash flows from financing activities:
Repayment to private placement debt holders					(100,000)	(25,000)
Proceeds from sales of common stock						158,820
Proceeds from convertible debt						983,175
Proceeds from short term loans, others					1,110,000	500,000
Repaid to note holders						(500,000)
Repaid to others					(35,000)	(60,000)
Net cash provided by financing activities					975,000	1,056,995
Net increase (decrease) in cash					26,570	(314,887)
Cash and restricted cash - beginning of period		$ 261,452		$ 588,769	261,452	588,769	588,769
Cash and restricted cash - end of period	$ 288,022		$ 273,882		288,022	273,882	$ 261,452
Supplemental cash flow information:
Interest paid					296,186	328,181
Income taxes paid
Non-cash investing and financing activities:
Warrants issued in connection with private placement					83,271	3,273,691
Common shares issued upon conversion of debt					433,179	573,001
Non-cash cost upon sale of common stock						79,180
Adoption of ASU 2020-06, net					(209,323)
Beneficial Conversion Feature on convertible debt and restricted common shares						$ 570,717